NGL Fine Chem — 360° view

NGL Fine Chem, a company in the Pharmaceuticals industry, reported revenue of ₹157 crore and net profit of ₹13 crore for the September 2026 quarter.

NGL Fine Chem (NSE: NGLFINE) closed at ₹2,747.60 on 20 Nov 2026, up 97.4% over the past year. Its market capitalisation is ₹1,698 crore and it trades at 26.6 times earnings.

Share price
₹2,747.60 (20 Nov 2026)
Market cap
₹1,698 Cr (20 Nov 2026)
P/E
26.61 (20 Nov 2026)
Revenue
₹157 Cr (September 2026 quarter)
Net profit
₹13 Cr (September 2026 quarter)
ROCE
16.7% (FY26)
ROE
15.6% (FY26)
Book value
₹564 (FY26)
Dividend yield
0.06% (last 12 months to 20 Nov 2026)
52-week high / low
₹3,602.00 / ₹1,271.00 (20 Nov 2026)
1-year return
97.4% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: NGLFINE

Incorporated in 1981, NGL Fine-Chem Ltd is a manufacturer and exporter of pharmaceuticals and intermediates for usage in veterinary and human health.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.